NantHealth Precision Insights
Oncologists use all the information available to make the best decisions for their patients. And yet, response rates for most cancer therapies remain low, with only 25% of cancer patients benefiting from the offered drug.
What if you could know more about each patient’s tumor? Could you drive up that 25%, and give your patients better outcomes?
When faced with a difficult treatment decision, NantHealth offers a comprehensive set of molecular profiling and decision support solutions that equip oncologists with actionable insights to inform evidence-based and personalized treatment strategies.
NantHealth Precision Insights includes the following:
- GPS Cancer — a precise and comprehensive tissue-based molecular profile, integrating tumor-normal sequencing of DNA with RNA expression with pharmacogenomic analysis of germline.
- Liquid GPS — a 26-analyte blood-based molecular test for noninvasive tumor profiling and quantitative monitoring of treatment response.
If you would like more information or assistance with the ordering process, please contact the GPS Care Center at 1-844-MY-OMICS or email us at GPS@NantHealth.com